 | | Plenary Session Presentation:
Immune system prevention
Sarah Rowland-Jones, MA, DM, MRCP, United Kingdom
Dr. Rowland-Jones is qualified in medicine from Cambridge and Oxford Universities, and trained in Infectious Diseases in London and Oxford. She began her research career in Oxford with a doctorate on the role of cellular immune responses to viral infections. Since then she has been leading a research group in the MRC Human Immunology Unit in the Weatherall Institute of Molecular Medicine in Oxford, studying the role played by cytotoxic T-cells in determining the outcome of HIV infection. A key focus of this work is the study of immune responses to HIV in highly exposed but apparently uninfected people, most notably sex workers in Nairobi, Kenya and the Gambia, and more recently in infants exposed to HIV at birth and through breast-feeding. The results of these studies have led to the development of a vaccine strategy designed to stimulate cellular immune responses, similar to those detected in the uninfected sex workers, which is currently being tested in clinical trials in Nairobi and Oxford.
Between 2001 and 2004, Dr. Rowland-Jones was Director of the Oxford Centre for Tropical Medicine, which coordinates research activities in tropical medicine and international health throughout the world, particularly in Wellcome Trust funded research units in Thailand, Vietnam and Kenya. Her developing interest in tropical medicine led in 2004 to her accepting a position as Director of Research in the MRC laboratories in the Gambia, the UK’s oldest and largest overseas research unit. She also holds a position as an Honorary Consultant in Infectious Diseases at the Churchill Hospital, and is a Fellow at Christ Church, Oxford.
PowerPoint presentation |
|
|